Status
Conditions
Treatments
About
This study aims to evaluate the effects of ultrasound-guided bilateral erector spinae plane block on intraoperative pain control and bleeding in patients undergoing major spinal surgery. Participants will be randomly assigned to two groups: one group will receive the Erector Spinae Plane block, while the other group will receive standard pain management. Primary outcomes include postoperative pain levels and intraoperative blood loss. This study seeks to determine whether the Erector Spinae Plane Block technique positively contributes to patient recovery and reduces bleeding complications.
Full description
This randomized controlled trial investigates the effectiveness of ultrasound-guided bilateral Erector Spinae Plane Block on intraoperative opioid consumption and bleeding in patients undergoing spinal surgery. Eligible adult patients will be enrolled after obtaining informed consent.
Participants will be randomly assigned to two groups: the intervention group will receive bilateral Erector Spinae Plane Block under ultrasound guidance before surgery, while the control group will receive standard pain management without the block. The Erector Spinae Plane Block will be performed using a standard dose of bupivacaine.
The primary outcome measure is the amount of intraoperative bleeding. Secondary outcomes include opioid consumption and incidence of complications.
This study aims to provide evidence on the efficacy of the Erector Spinae Plane Block technique in improving postoperative recovery and reducing bleeding complications in major spinal surgeries.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria:
Scheduled for elective spinal stabilization surgery
American Society of Anesthesiologists (ASA) physical status I-III
Provided written informed consent
Exclusion Criteria: Coagulopathy or current anticoagulant therapy
Anatomical barrier or infection at the Erector Spinae Plane Block site
Known allergy to local anesthetics or opioids
-
Primary purpose
Allocation
Interventional model
Masking
120 participants in 2 patient groups
Loading...
Central trial contact
Derya Özkan, Prof; Funda Atar, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal